Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02536716 · ClinicalTrials.gov registry record · NA

The Effect of Platform-Matching Versus Platform-Switching Dental Implants on Peri-implant Hard and Soft Tissue Healing

A NA study, sponsored by University of Louisville.

Completed
Registry status
NA
Development phase
24
Enrollment target

NCT02536716: Completed NA study, sponsored by University of Louisville.

NCT02536716 is a NA study that has completed, run by University of Louisville. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02536716, a NA study, has completed, sponsored by University of Louisville.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target

Study Summary

To compare platform-switched implants to platform-matched implants for replacement of a single missing tooth and their effect on: 1) Interproximal alveolar crest level in relation to implant platform. 2) Buccal implant recession. 3) Presence or absence of black triangle apical to the contact point. 4) Implant Success. 5) Adequate buccal tissue thickness.

Primary Outcome

Bone loss will be measured radiographically using a stent

Interventions

  • PROCEDURE Platform-matched dental implant
  • PROCEDURE Platform-switched dental implant

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2016-01-12
Est. Completion 2017-07-21
Phase NA
University of Louisville

217 total trials

What the finished NCT02536716 record still lists

NCT02536716 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Platform-matched dental implant is the first listed.

NCT02536716 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02536716 about?

NCT02536716 is a clinical study titled "The Effect of Platform-Matching Versus Platform-Switching Dental Implants on Peri-implant Hard and Soft Tissue Healing". To compare platform-switched implants to platform-matched implants for replacement of a single missing tooth and their effect on: 1) Interproximal alveolar crest level in relation to implant platform. 2) Buccal implant recession. 3) Presence or absence of black triangle apical to the contact point. ...

What is the current status of trial NCT02536716?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2016-01-12. Estimated completion is 2017-07-21.

What interventions are being tested in trial NCT02536716?

The interventions under investigation include: Platform-matched dental implant (PROCEDURE), Platform-switched dental implant (PROCEDURE).

Who is sponsoring clinical trial NCT02536716?

This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02536716's enrollment target sits among peer trials

24 1736th of 2000 higher than 246 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02536716, the US trial registry maintained by the National Library of Medicine. NCT02536716 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.